Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05256485
Other study ID # RPC£0521190906
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 15, 2019
Est. completion date October 10, 2021

Study information

Verified date February 2022
Source Alexandria University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

the study aim is to compare betwenn the effect of mindfulness based relapse prevention and other evidence based psychotherapy interventions regaring substance craving.


Description:

In this prospective study, the population included opioid-dependent men (aged 18-50 years), some of them were admitted to El Maamora hospital and others were attendees in NA. To conduct this research, considering the drop-out rate, the list of 60 persons applying for treatment was prepared based on inclusion and exclusion criteria. Then, three groups of 20 were randomly selected and placed in three intervention groups, group one received CBT, group two received MBRP, and group three received twelve-step therapy. The subjects were assigned randomly to the treatment condition via a computer-generated random number with the aid of trained staff at the clinic blindly. All participants completed the measurement scales immediately after detoxification (pre-test) and after the end of therapeutic sessions (post-test).


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date October 10, 2021
Est. primary completion date June 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 15 Years to 50 Years
Eligibility Inclusion Criteria: - Age: 15-50 years. - Male gender. - Patients meet DSM-5(3) criteria of opioid abuse. - Had completed detoxification in a treatment center. - Willing to give consent they will be randomly assigned to either CBT, MBRP, or twelve-step treatment group. - Patients have dual diagnoses. - Patients have poly-substance use disorder. Exclusion Criteria: - Participants with significant cognitive disorder. - Participants with suicidal thoughts. - Participants with any organic condition affecting stress response and so craving such as hypertension, respiratory or cardiovascular disorders. - Participants taking any medications (e.g., antipsychotics in high doses) known to affect the stress response. - Participants relapsed to drug abuse during therapy.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
cognitive behavioral therapy,mindfulness based relapse prevention,twelve-step therapy
In cognitive-behavioral therapy, participants learned that thoughts and emotions contribute to behavior, and responses to thoughts and emotions can be controlled. in mindfulness-based relapse prevention, participants learned to focus on the present moment experience including craving with an attitude of acceptance and non-judging. In twelve-step therapy, participants learned principles of acceptance, gratitude, forgiveness, tolerance, patience, humility, and honesty together with participation in different healthy ways to enrich life.

Locations

Country Name City State
Egypt Sara Harby Alexandria

Sponsors (1)

Lead Sponsor Collaborator
Sara Harby

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary opioid craving scale A visual analog scale, a modification of the Cocaine Craving Scale, is a 3-item scale used to measure the opioid craving and each item is ranging from 0 to 10 (0 means no craving at all and 10 means severe craving). 5 minutes
Secondary The Obsessive-Compulsive Drug use Scale it measures craving in the previous ten days and includes 13 questions. Subjects should select from 5 graded options for each question based on their experiences during last week. The items were rated as follow:1) Never; 2) Rarely; 3) Sometimes; 4) Mostly and 5) Always 15 minutes
Secondary The desire for a drug questionnaire it measures instant (now) craving, includes 14 questions and participants answer questions on a seven-step Likert-scale answer sheet based on what he/she feels or thinks at the moment. The items were rated as follows: 1) not at all; 2) mild; 3) mild to moderate; 4) moderate; 5) moderate to severe; 6) severe and 7) approximately complete 15 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT05361603 - Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Recruiting NCT03952455 - Deep Brain Stimulation of the Bilateral Nucleus Accumbens for Patients With Methadone Maintenance Treatment N/A
Recruiting NCT06266039 - Introduction of Long Acting Buprenorphine in France
Recruiting NCT05161351 - Evaluating the Safety of Acute Baclofen in Methadone-maintained Individuals With Opiate Dependence. Phase 4
Withdrawn NCT04464512 - Suboxone User Perioperative Early Referral and Enhanced Recovery After Surgery- Orthopaedic Trauma Surgery Population Phase 4
Completed NCT05431985 - Cross-cultural Validation of a Screening Scale for the Misuse of Opioid Analgesics in Primary Care